PTK2 and breast carcinoma: NRF2 activation in breast cancer enhances the expression of Rho and its downstream proteins like Focal adhesion kinase 1 (FAK) and Modulator of volume-regulated anion channel current 1 (MLC), while suppressing estrogen-related receptor α (ERR1) (23).